Bone Biologics (NASDAQ:BBLGW) Trading Down 25.9% – Here’s Why

Bone Biologics Co. (NASDAQ:BBLGW) shares dropped 25.9% during trading on Monday . The stock traded as low as $20.00 and last traded at $20.00. Approximately 127 shares traded hands during trading, a decline of 94% from the average daily volume of 2,049 shares. The stock had previously closed at $27.00.

Bone Biologics Price Performance

The business has a 50-day simple moving average of $23.17 and a 200-day simple moving average of $17.52.

About Bone Biologics

Bone Biologics, Inc is a clinical-stage biopharmaceutical company focused on developing protein-based therapeutics designed to promote bone healing and regeneration in acute and chronic orthopedic conditions. Its proprietary platform combines key osteogenic growth factors with engineered delivery matrices to support repair in complex fractures, spinal fusion procedures and non-union bone injuries. By targeting the biology of bone formation, the company aims to overcome limitations associated with autografts, allografts and synthetic implants.

The company’s lead candidate is advancing through preclinical evaluation, with studies assessing efficacy in animal models of fracture repair and spinal arthrodesis.